11 Jan 2023 8:00 AM - 1:00 PM PST
Please join Morrison Foerster at the 2023 Chinese American Bio/Pharmaceutical Society (CABS) Investor Forum on January 11, 2023 from 8:00 AM – 1:00 PM (Pacific) in conjunction with the J.P. Morgan Healthcare Conference. This event will be hybrid, with in-person programing hosted in Morrison Foerster's San Francisco office.
In the post-COVID era, pharmaceutical innovation, medical technology, and healthcare continue to be major areas of licensing and venture capital investment globally. The forum will feature two panel discussions including investors, lawyers, business development executives, and entrepreneurs. Topics will focus on investment trends, licensing and strategic considerations as well as new opportunities and challenges in life sciences.
MoFo Partner and Head of the firm's China Life Sciences group, Janet Xiao, will moderate Panel One: Trends, Opportunities, and Outlook for Biotech Investment.
Panelists include:
- Christian Grøndahl, Co-founder and CEO, SNIPR Biome
- Sean Kendall, Partner, ARCH Venture
- Jim Krenn, Partner, Morrison Foerster
- Arthur Kuan, CEO, CG Oncology
- Cheni Kwok, Managing Partner and Founder, Linear Dreams
In-person registration is complimentary, and the deadline for in-person registration is 3:00PM (Pacific) on January 5, 2023.
If you are interested in attending this event virtually (also complimentary), please register here.
View more information on the website.